Moderna has been using artificial intelligence (AI) for years to save precious time in the laboratory. But the biotech isn't stopping there.
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the Financial Times reported on Friday.